Live Analyst Rating Changes 8035 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Rajesh Kumar
HSBC
Rajesh Kumar
HSBC
Wall Street Analyst
★★★☆☆
#1023
on 13Foresight · ranked by our own returns
58%
Success Rate
+11.5%
Average Return
14 of 24 calls profitable · -191.1% vs benchmark
📈 Across the calls we could measure, roughly 58% of Rajesh Kumar's ratings turned a profit when each position was held for 1 year — averaging +11.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

27 Buy 17 Hold 5 Sell
Rajesh's Stock Coverage 48 ratings · 2026-07-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
CVS
CVS Health
 Jul 06, 2026 HOLD Strong Buy
-1.6% avg upside
39 analysts
$103.00
1.16% Downside
 +2.0%
CH:LONN
Lonza Group Ltd
 Jul 06, 2026 BUY Strong Buy
+9.8% avg upside
20 analysts
$640.00
9.22% Upside
 ·
CH:ROP
Roche Holding AG
 Jul 06, 2026 HOLD Buy
-1.2% avg upside
23 analysts
$365.00
8.34% Upside
 ·
GB:0QIU
Novo Nordisk
 Jul 06, 2026 HOLD Hold
+27.4% avg upside
29 analysts
$300.00
6.62% Downside
 ·
GB:GSK
GlaxoSmithKline
 Jul 06, 2026 HOLD Hold
-3.3% avg upside
25 analysts
$1860.00
5.08% Downside
 ·
GB:AZN
AstraZeneca
 Jul 06, 2026 BUY Strong Buy
+16.5% avg upside
26 analysts
$16500.00
28.65% Upside
 ·
ABBV
AbbVie
 Jul 06, 2026 BUY Strong Buy
-6.7% avg upside
46 analysts
$300.00
20.91% Upside
 -2.6%
REGN
Regeneron
 Jul 06, 2026 BUY Strong Buy
+16.2% avg upside
58 analysts
$800.00
20.43% Upside
 +2.3%
PFE
Pfizer
 Jul 06, 2026 HOLD Buy
+39.2% avg upside
45 analysts
$28.00
15.93% Upside
 +1.9%
MRK
Merck & Company
 Jul 06, 2026 BUY Strong Buy
+4.0% avg upside
43 analysts
$150.00
21.51% Upside
 -2.6%
FR:DIM
Sartorius Stedim Biotech
 Jun 03, 2026 BUY Strong Buy
+36.4% avg upside
11 analysts
$230.00
25.44% Upside
 ·
LLY
Eli Lilly & Co
 Mar 17, 2026 SELL Strong Buy
-13.6% avg upside
47 analysts
$850.00
28.56% Downside
 -28.0%
CH:NOVN
Novartis AG
 Mar 17, 2026 SELL Buy
-13.7% avg upside
31 analysts
$95.00
23.48% Downside
 ·
BMY
Bristol-Myers Squibb
 Mar 17, 2026 HOLD Buy
+2.3% avg upside
42 analysts
$60.00
4.17% Upside
 -1.5%
NVO
Novo Nordisk
 Dec 10, 2025 HOLD Buy
+134.5% avg upside
26 analysts
$54.00
9.21% Upside
 +4.6%
FR:SAN
Sanofi
 Dec 10, 2025 BUY Strong Buy
+29.1% avg upside
30 analysts
$100.00
31.14% Upside
 ·
DE:BAYN
Bayer
 Dec 10, 2025 BUY Strong Buy
+3.9% avg upside
28 analysts
$40.00
20.26% Downside
 ·
RHHBY
Roche Holding
 Dec 10, 2025 BUY Buy
-3.9% avg upside
14 analysts
$57.00
9.91% Upside
 +5.2%
NVS
Novartis
 Dec 10, 2025 SELL Hold
-11.8% avg upside
24 analysts
$112.00
27.29% Downside
 -21.0%
SNY
Sanofi
 Dec 02, 2025 BUY Strong Buy
+68.9% avg upside
20 analysts
$114.47
163.13% Upside
 -7.0%
ROG
Rogers
 Dec 02, 2025 BUY Strong Buy
+102.8% avg upside
6 analysts
$453.88
229.97% Upside
 +59.1%
TEVA
Teva Pharmaceutical
 Apr 28, 2025 BUY Buy
-10.8% avg upside
39 analysts
$20.00
39.36% Downside
 +110.5%
GB:0MGB
Genmab A/S
 Apr 28, 2025 BUY Strong Buy
+14.3% avg upside
22 analysts
$1990.00
5.23% Upside
 ·
GB:0NZT
UCB SA
 Apr 28, 2025 BUY Buy
-8.4% avg upside
19 analysts
$179.00
27.19% Downside
 ·
GILD
Gilead Sciences
 Dec 04, 2024 HOLD Strong Buy
-8.3% avg upside
66 analysts
$82.00
36.85% Downside
 +37.9%
IQV
IQVIA Holdings
 Dec 04, 2024 BUY Strong Buy
+8.5% avg upside
38 analysts
$270.00
29.84% Upside
 +10.7%
TMO
Thermo Fisher
 Apr 30, 2024 BUY Strong Buy
+11.5% avg upside
38 analysts
$670.00
27.17% Upside
 -24.3%
DHR
Danaher
 Apr 16, 2024 BUY Strong Buy
+8.5% avg upside
45 analysts
$280.00
40.61% Upside
 -20.3%
MRNA
Moderna
 Feb 26, 2024 SELL Hold
+1.6% avg upside
38 analysts
$86.00
25.92% Upside
 +64.3%
FERG
Ferguson PLC
 Feb 14, 2024 BUY Strong Buy
+62.8% avg upside
35 analysts
$237.41
4.45% Upside
 -3.2%
DE:MRK
Merck KGaA
 Dec 18, 2023 BUY Buy
-2.8% avg upside
33 analysts
$170.00
21.66% Upside
 ·
BNTX
BioNTech SE
 Oct 16, 2023 HOLD Strong Buy
+49.1% avg upside
26 analysts
$111.00
21.32% Upside
 +21.4%
SE:SOBI
Swedish Orphan Biovitrum AB
 Sep 01, 2023 BUY Strong Buy
-13.9% avg upside
7 analysts
$260.00
44.91% Downside
 ·
GB:CTEC
ConvaTec
 Mar 22, 2023 SELL Strong Buy
+36.4% avg upside
17 analysts
$200.00
6.53% Downside
 ·
DE:FME
Fresenius Medical Care AG & Co. KGaA
 Mar 07, 2023 SELL Hold
+21.6% avg upside
22 analysts
$33.00
21.34% Downside
 ·
GB:DCC
DCC plc
 Dec 09, 2022 BUY Strong Buy
+0.2% avg upside
10 analysts
$6565.00
4.70% Upside
 ·
GB:BNZL
Bunzl plc
 Oct 20, 2022 HOLD Buy
+0.9% avg upside
16 analysts
$2880.00
7.17% Upside
 ·
CH:SGSN
SGS SA
 Apr 08, 2022 HOLD Buy
+1133.2% avg upside
26 analysts
$2860.00
2920.65% Upside
 ·
FR:ERF
Eurofins Scientific
 Apr 08, 2022 HOLD Buy
+44.3% avg upside
17 analysts
$92.00
33.33% Upside
 ·
FR:BVI
Bureau Veritas
 Apr 08, 2022 BUY Buy
+7.1% avg upside
25 analysts
$31.00
13.94% Upside
 ·
GB:ITRK
Intertek
 Apr 08, 2022 HOLD Hold
+796.4% avg upside
23 analysts
$5700.00
1.93% Downside
 ·
GB:INF
Informa
 Jan 26, 2022 BUY Strong Buy
+533.9% avg upside
18 analysts
$685.00
23.34% Downside
 ·
DE:BNR
Brenntag AG
 Sep 28, 2021 BUY Buy
+21.3% avg upside
25 analysts
$96.00
70.75% Upside
 ·
NL:IMCD
IMCD N.V.
 Sep 28, 2021 BUY Buy
+50.5% avg upside
16 analysts
$195.00
128.17% Upside
 ·
GB:EXPN
Experian
 Mar 19, 2021 BUY Buy
+269.5% avg upside
19 analysts
$3200.00
22.21% Upside
 ·
GB:RS1
RS Group PLC
 Jan 13, 2021 BUY Strong Buy
+23.3% avg upside
10 analysts
$1000.00
62.01% Upside
 ·
EXPGY
Experian
 May 06, 2020 BUY Buy
+6.0% avg upside
8 analysts
 — +27.8%
GB:DPLM
Diploma
 Apr 06, 2020 HOLD Strong Buy
-19.6% avg upside
8 analysts
$1370.00
79.79% Downside
 ·
🔒 43 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Rajesh Kumar — Frequently Asked Questions
How accurate are Rajesh Kumar's stock ratings?
Based on the calls 13Foresight could measure, about 58% of Rajesh's ratings were profitable over a one-year hold, with an average return of +11.4% per rating, or -1.9% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Rajesh ranked on 13Foresight?
Rajesh Kumar is currently ranked #1023 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Rajesh cover?
Rajesh most recently has ratings on CVS, CH:LONN, CH:ROP, GB:0QIU, GB:GSK, GB:AZN, ABBV, REGN, PFE, MRK, FR:DIM, LLY and 36 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.